FDA Takes A Major Step to Advance Its Focus on Genomics and Related Fields of Science: An Update on the Current State of Personalized Medicine

In early February 2009, the FDA created a new position in the Office of FDA’s Chief Scientist dedicated to coordinating and upgrading FDA’s activities involving genomics and the related fields of science that are involved in the analysis of complex DNA, protein and small molecular expression patterns. The use of genomic information, accelerated by the sequencing of the human genome and the advent of new tools and technologies, has opened new possibilities in drug discovery and development. Consequently, this step is a welcome acknowledgement by the FDA that it is serious about accepting its responsibility to advance this new era of personalized medicine and personalized health records.


Click the link below to read the full alert.